SOLID TUMOURS:@0.084848:0.038601:0.266058:0.038601:0.266058:0.019343:0.084848:0.019343:0.011712:0.020438:0.010866:0.005315:0.017498:0.006515:0.010019:0.015405:0.021613:0.020438:0.015405:0.014276:0.011712
34:@0.023705:0.038809:0.044778:0.038809:0.044778:0.019212:0.023705:0.019212:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.084848:0.970015:0.320957:0.970015:0.320957:0.956010:0.084848:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
dependent on the anatomical location of :@0.084848:0.096166:0.481107:0.096166:0.481107:0.080410:0.084848:0.080410:0.013181:0.012508:0.013123:0.012508:0.011738:0.013181:0.012508:0.011738:0.006523:0.004984:0.012604:0.011738:0.004984:0.006523:0.011738:0.012508:0.004984:0.013143:0.011738:0.013143:0.006523:0.012604:0.018049:0.003848:0.012450:0.013143:0.003848:0.004984:0.003848:0.012604:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.004984:0.012604:0.006042:0.005330
the tumour. The tissue obtained would be :@0.084848:0.112636:0.481109:0.112636:0.481109:0.096880:0.084848:0.096880:0.006523:0.011738:0.012508:0.006377:0.006523:0.011699:0.018049:0.012604:0.011699:0.004372:0.005330:0.006388:0.008197:0.011738:0.012498:0.006388:0.006523:0.003848:0.007466:0.007466:0.011699:0.012508:0.006388:0.012604:0.013123:0.006523:0.013143:0.003848:0.011738:0.012508:0.013181:0.006388:0.015990:0.012604:0.011699:0.003848:0.013181:0.006388:0.013123:0.012508:0.005330
tested for genetic mutations.:@0.084848:0.129106:0.353434:0.129106:0.353434:0.113350:0.084848:0.113350:0.006523:0.012508:0.007466:0.006523:0.012508:0.013181:0.005330:0.006042:0.012604:0.005792:0.005330:0.012950:0.012508:0.011738:0.012508:0.006523:0.003848:0.012450:0.005330:0.018049:0.011699:0.006523:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330
A CT-scan of the chest and upper abdo-:@0.084848:0.145577:0.475765:0.145577:0.475765:0.129821:0.084848:0.129821:0.014239:0.006970:0.015644:0.008197:0.006388:0.007466:0.012450:0.013143:0.011738:0.006975:0.012604:0.006042:0.006970:0.006523:0.011738:0.012508:0.006972:0.012450:0.011738:0.012508:0.007466:0.006523:0.006972:0.013143:0.011738:0.013181:0.006975:0.011699:0.013123:0.013123:0.012508:0.005792:0.006973:0.013143:0.013123:0.013181:0.012604:0.006388
men is indicated to evaluate the extent :@0.084848:0.162047:0.481088:0.162047:0.481088:0.146291:0.084848:0.146291:0.018049:0.012508:0.011738:0.008986:0.003848:0.007466:0.008986:0.003848:0.011738:0.013181:0.003848:0.012450:0.013143:0.006523:0.012508:0.013181:0.008986:0.006523:0.012604:0.008986:0.012508:0.010660:0.013143:0.003848:0.011699:0.013143:0.006523:0.012508:0.008986:0.006523:0.011738:0.012508:0.008986:0.012508:0.009236:0.006523:0.012508:0.011738:0.006523:0.005330
of  disease. A  bone  scan is indicated for :@0.084848:0.178517:0.481103:0.178517:0.481103:0.162761:0.084848:0.162761:0.012604:0.006042:0.005330:0.003469:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330:0.008813:0.014239:0.005330:0.003471:0.013123:0.012604:0.011738:0.012508:0.005330:0.003466:0.007466:0.012450:0.013143:0.011738:0.008813:0.003848:0.007466:0.008813:0.003848:0.011738:0.013181:0.003848:0.012450:0.013143:0.006523:0.012508:0.013181:0.008813:0.006042:0.012604:0.005792:0.005330
patients with bone pain and an elevated :@0.084848:0.194987:0.481111:0.194987:0.481111:0.179232:0.084848:0.179232:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.006388:0.015990:0.003848:0.006523:0.011738:0.006388:0.013123:0.012604:0.011738:0.012508:0.006373:0.013123:0.013143:0.003848:0.011738:0.006388:0.013143:0.011738:0.013181:0.006388:0.013143:0.011738:0.006388:0.012508:0.003848:0.012508:0.010660:0.013143:0.006523:0.012508:0.013181:0.005330
alkaline phosphatase.:@0.084848:0.211458:0.289818:0.211458:0.289818:0.195702:0.084848:0.195702:0.013143:0.003848:0.009660:0.013143:0.003848:0.003848:0.011738:0.012508:0.005330:0.013123:0.011738:0.012604:0.007466:0.013123:0.011738:0.013143:0.006523:0.013143:0.007466:0.012508:0.005330
Positron  emission  tomography (PET)  is :@0.103032:0.227928:0.481090:0.227928:0.481090:0.212172:0.103032:0.212172:0.011392:0.012604:0.007466:0.003848:0.006523:0.005709:0.012604:0.011738:0.005330:0.007429:0.012508:0.018049:0.003848:0.007466:0.007466:0.003860:0.012604:0.011738:0.005330:0.007429:0.006523:0.012604:0.018049:0.012604:0.012950:0.005792:0.013143:0.013123:0.011722:0.010314:0.012777:0.007100:0.011392:0.010314:0.008197:0.007100:0.005330:0.007435:0.003848:0.007466:0.005330
an important investigation in selected pa-:@0.084848:0.244398:0.475767:0.244398:0.475767:0.228642:0.084848:0.228642:0.013143:0.011738:0.005619:0.003848:0.018049:0.013123:0.012604:0.005792:0.006523:0.013143:0.011738:0.006523:0.005601:0.003848:0.011738:0.010660:0.012508:0.007466:0.006523:0.003848:0.012950:0.013143:0.006523:0.003848:0.012604:0.011738:0.005619:0.003848:0.011738:0.005619:0.007466:0.012508:0.003848:0.012508:0.012450:0.006523:0.012508:0.013181:0.005607:0.013123:0.013143:0.006388
tients. It is used to detect occult metasta-:@0.084848:0.260869:0.475752:0.260869:0.475752:0.245113:0.084848:0.245113:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.006254:0.004349:0.006523:0.006254:0.003848:0.007466:0.006267:0.011699:0.007466:0.012508:0.013181:0.006254:0.006523:0.012604:0.006254:0.013181:0.012508:0.006523:0.012508:0.012450:0.006523:0.006254:0.012604:0.012450:0.012450:0.011699:0.003848:0.006523:0.006254:0.018049:0.012508:0.006523:0.013143:0.007466:0.006523:0.013143:0.006388
ses in patients who  have potentially cur-:@0.084848:0.277339:0.475798:0.277339:0.475798:0.261583:0.084848:0.261583:0.007466:0.012508:0.007466:0.008390:0.003848:0.011738:0.008390:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.008390:0.015990:0.011738:0.012604:0.005330:0.003042:0.011738:0.013143:0.010660:0.012508:0.008390:0.013123:0.012604:0.006523:0.012508:0.011738:0.006523:0.003848:0.013143:0.003848:0.003848:0.010314:0.008390:0.012450:0.011699:0.005792:0.006388
able disease.  However,  it  can  be  falsely :@0.084848:0.293809:0.481074:0.293809:0.481074:0.278053:0.084848:0.278053:0.013143:0.013123:0.003848:0.012508:0.009313:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330:0.005330:0.003974:0.013143:0.012604:0.015990:0.012508:0.010660:0.012508:0.003764:0.005330:0.005330:0.003968:0.003848:0.006523:0.005330:0.003972:0.012450:0.013143:0.011738:0.005330:0.003968:0.013123:0.012508:0.005330:0.003972:0.006042:0.013143:0.003848:0.007466:0.012508:0.003848:0.010314:0.005330
positive  from  inflammatory  conditions  or :@0.084848:0.310280:0.481092:0.310280:0.481092:0.294524:0.084848:0.294524:0.013123:0.012604:0.007466:0.003848:0.006523:0.003848:0.010660:0.012508:0.005330:0.004930:0.006042:0.005711:0.012604:0.018049:0.005330:0.004916:0.003848:0.011738:0.004666:0.004666:0.013143:0.018049:0.018049:0.013143:0.006523:0.012604:0.005792:0.010314:0.005330:0.004911:0.012450:0.012604:0.011738:0.013181:0.003848:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330:0.004916:0.012604:0.005792:0.005330
diseases (e.g., TB and autoimmune diseas-:@0.084848:0.326750:0.475758:0.326750:0.475758:0.310994:0.084848:0.310994:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.007466:0.004734:0.007100:0.012508:0.005330:0.012950:0.005330:0.005330:0.004711:0.008197:0.011045:0.004720:0.013143:0.011738:0.013181:0.004722:0.013143:0.011699:0.006523:0.012604:0.003848:0.018049:0.018049:0.011699:0.011738:0.012508:0.004711:0.013181:0.003848:0.007466:0.012508:0.013143:0.007480:0.006388
es). The findings need to be confirmed his-:@0.084848:0.343220:0.475752:0.343220:0.475752:0.327464:0.084848:0.327464:0.012508:0.007466:0.007100:0.005330:0.005065:0.008197:0.011738:0.012508:0.005055:0.004686:0.004686:0.011738:0.013181:0.003848:0.011738:0.012950:0.007466:0.005059:0.011738:0.012508:0.012508:0.013181:0.005059:0.006523:0.012604:0.005055:0.013123:0.012508:0.005065:0.012450:0.012604:0.011738:0.004686:0.004686:0.006312:0.018049:0.012508:0.013181:0.005063:0.011738:0.003848:0.007466:0.006388
tologically. It can also be falsely negative :@0.084848:0.359691:0.481069:0.359691:0.481069:0.343935:0.084848:0.343935:0.006523:0.012604:0.003848:0.012604:0.012950:0.003848:0.012450:0.013143:0.003848:0.003848:0.010314:0.005330:0.006273:0.004349:0.006523:0.006273:0.012450:0.013143:0.011738:0.006273:0.013143:0.003848:0.007466:0.012604:0.006273:0.013123:0.012508:0.006273:0.006042:0.013143:0.003848:0.007466:0.012508:0.003848:0.010314:0.006273:0.011738:0.012508:0.012950:0.013143:0.006523:0.003848:0.010660:0.012508:0.005330
in diseases with a low metabolic activity, :@0.084848:0.376161:0.481042:0.376161:0.481042:0.360405:0.084848:0.360405:0.003848:0.011738:0.007543:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.007466:0.007555:0.015990:0.003848:0.006523:0.011738:0.007543:0.013143:0.007543:0.003848:0.012604:0.015990:0.007543:0.018049:0.012508:0.006523:0.013143:0.013123:0.012604:0.003848:0.003848:0.012450:0.007543:0.013143:0.012450:0.006523:0.003848:0.010660:0.003848:0.006523:0.010314:0.005330:0.005330
e.g., minimally invasive adenocarcinoma.:@0.084848:0.392631:0.474436:0.392631:0.474436:0.376875:0.084848:0.376875:0.012508:0.005330:0.012950:0.005330:0.005330:0.005330:0.018049:0.003848:0.011738:0.003848:0.018049:0.013143:0.003848:0.003848:0.010314:0.005330:0.003848:0.011738:0.010660:0.013143:0.007466:0.003848:0.010660:0.012508:0.005330:0.013143:0.013181:0.012508:0.011738:0.012604:0.012450:0.013143:0.005663:0.012450:0.003848:0.011738:0.012604:0.018049:0.013143:0.005330
The  gold standard for  sampling en-:@0.103032:0.409102:0.475783:0.409102:0.475783:0.393346:0.103032:0.393346:0.008197:0.011738:0.012508:0.005330:0.009546:0.012950:0.012604:0.003848:0.013181:0.014894:0.007466:0.006523:0.013143:0.011738:0.013181:0.013143:0.005678:0.013181:0.014894:0.006042:0.012604:0.005792:0.005330:0.009546:0.007466:0.013143:0.018049:0.013123:0.003848:0.003848:0.011738:0.012950:0.014894:0.012508:0.011738:0.006388
larged or FDG-avid lymph nodes is a me-:@0.084848:0.425572:0.475748:0.425572:0.475748:0.409816:0.084848:0.409816:0.003848:0.013143:0.005813:0.012950:0.012508:0.013181:0.006773:0.012604:0.005792:0.006773:0.009333:0.014316:0.016779:0.006388:0.013143:0.010660:0.003848:0.013181:0.006789:0.003848:0.010314:0.018049:0.013123:0.011738:0.006773:0.011738:0.012604:0.013181:0.012508:0.007466:0.006773:0.003848:0.007466:0.006785:0.013143:0.006773:0.018049:0.012508:0.006388
diastinoscopy. This confirms that the nodes :@0.084848:0.442042:0.481092:0.442042:0.481092:0.426286:0.084848:0.426286:0.013181:0.003848:0.013143:0.007466:0.006523:0.003848:0.011738:0.012604:0.007466:0.012450:0.012604:0.013123:0.010314:0.005330:0.004376:0.008197:0.011738:0.003848:0.007466:0.004370:0.012450:0.012604:0.011738:0.004686:0.004686:0.006312:0.018049:0.007466:0.004372:0.006523:0.011738:0.013143:0.006523:0.004364:0.006523:0.011738:0.012508:0.004362:0.011738:0.012604:0.013181:0.012508:0.007466:0.005330
are large  because of  metastatic lung :@0.084848:0.458512:0.481107:0.458512:0.481107:0.442757:0.084848:0.442757:0.013143:0.005715:0.012508:0.013874:0.003848:0.013143:0.005811:0.012950:0.012508:0.005330:0.008534:0.013123:0.012508:0.012450:0.013143:0.011699:0.007466:0.012508:0.013874:0.012604:0.006042:0.005330:0.008534:0.018049:0.012508:0.006523:0.013143:0.007466:0.006523:0.013143:0.006523:0.003848:0.012450:0.013874:0.003848:0.011699:0.011738:0.012950:0.005330
cancer. Endobronchial and endoscopic :@0.084848:0.474983:0.481094:0.474983:0.481094:0.459227:0.084848:0.459227:0.012450:0.013143:0.011738:0.012450:0.012508:0.004376:0.005330:0.010949:0.010314:0.011738:0.013181:0.012604:0.013123:0.005713:0.012604:0.011738:0.012450:0.011738:0.003848:0.013143:0.003848:0.010949:0.013143:0.011738:0.013181:0.010949:0.012508:0.011738:0.013181:0.012604:0.007466:0.012450:0.012604:0.013123:0.003848:0.012450:0.005330
ultrasound-guided  biopsies are  alterna-:@0.084848:0.491453:0.475748:0.491453:0.475748:0.475697:0.084848:0.475697:0.011699:0.003848:0.006523:0.005792:0.013143:0.007466:0.012604:0.011699:0.011738:0.013181:0.006388:0.012950:0.011699:0.003848:0.013181:0.012508:0.013181:0.005330:0.008203:0.013123:0.003848:0.012604:0.013123:0.007466:0.003848:0.012508:0.007466:0.013547:0.013143:0.005713:0.012508:0.005330:0.008207:0.013143:0.003848:0.006523:0.012508:0.006192:0.011738:0.013143:0.006388
tive procedures. These procedures are less :@0.084848:0.507923:0.481094:0.507923:0.481094:0.492167:0.084848:0.492167:0.006523:0.003848:0.010660:0.012508:0.004618:0.013123:0.005715:0.012604:0.012450:0.012508:0.013181:0.011699:0.005709:0.012508:0.007466:0.005330:0.004609:0.008197:0.011738:0.012508:0.007466:0.012508:0.004603:0.013123:0.005715:0.012604:0.012450:0.012508:0.013181:0.011699:0.005705:0.012508:0.007466:0.004618:0.013143:0.005715:0.012508:0.004607:0.003848:0.012508:0.007466:0.007466:0.005330
invasive, and can be done in-office. Hilar :@0.084848:0.524394:0.481078:0.524394:0.481078:0.508638:0.084848:0.508638:0.003848:0.011738:0.010660:0.013143:0.007466:0.003848:0.010660:0.012508:0.005330:0.006781:0.013143:0.011738:0.013181:0.006766:0.012450:0.013143:0.011738:0.006766:0.013123:0.012508:0.006768:0.013181:0.012604:0.011738:0.012508:0.006758:0.003848:0.011738:0.006388:0.012604:0.006042:0.004686:0.004686:0.012450:0.012508:0.005330:0.006754:0.013143:0.003848:0.003848:0.013143:0.005792:0.005330
lymph nodes can also be sampled.:@0.084848:0.540864:0.412739:0.540864:0.412739:0.525108:0.084848:0.525108:0.003848:0.010314:0.018049:0.013123:0.011738:0.005330:0.011738:0.012604:0.013181:0.012508:0.007466:0.005330:0.012450:0.013143:0.011738:0.005330:0.013143:0.003848:0.007466:0.012604:0.005330:0.013123:0.012508:0.005330:0.007466:0.013143:0.018049:0.013123:0.003848:0.012508:0.013181:0.005330
The  forced expiratory  volume in one :@0.103032:0.557334:0.481115:0.557334:0.481115:0.541578:0.103032:0.541578:0.008197:0.011738:0.012508:0.005330:0.007299:0.006042:0.012604:0.005651:0.012450:0.012508:0.013181:0.012642:0.012508:0.009236:0.013123:0.003848:0.005792:0.013143:0.006523:0.012604:0.005792:0.010314:0.005330:0.007301:0.010660:0.012604:0.003848:0.011699:0.018049:0.012508:0.012642:0.003848:0.011738:0.012642:0.012604:0.011738:0.012508:0.005330
second (FEV1)  is used to assess  the pa-:@0.084848:0.573805:0.475765:0.573805:0.475765:0.558049:0.084848:0.558049:0.007466:0.012508:0.012450:0.012604:0.011738:0.013181:0.009814:0.007100:0.009333:0.010314:0.013508:0.010660:0.007100:0.005330:0.004497:0.003848:0.007466:0.009814:0.011699:0.007466:0.012508:0.013181:0.009814:0.006523:0.012604:0.009814:0.013143:0.007466:0.007466:0.012508:0.007466:0.007466:0.005330:0.004497:0.006523:0.011738:0.012508:0.009814:0.013123:0.013143:0.006388
tient’s ability to tolerate surgery. The post-:@0.084848:0.590275:0.475760:0.590275:0.475760:0.574519:0.084848:0.574519:0.006523:0.003848:0.012508:0.011738:0.006523:0.006754:0.007466:0.006321:0.013143:0.013123:0.003848:0.003848:0.003848:0.006523:0.010314:0.006331:0.006523:0.012604:0.006321:0.006523:0.012604:0.003848:0.012508:0.005792:0.013143:0.006523:0.012508:0.006312:0.007466:0.011699:0.005807:0.012950:0.012508:0.005792:0.010314:0.005330:0.006317:0.008197:0.011738:0.012508:0.006312:0.013123:0.012604:0.007466:0.006523:0.006388
operative predicted FEV1 needs to be :@0.084848:0.606745:0.481088:0.606745:0.481088:0.590989:0.084848:0.590989:0.012604:0.013123:0.012508:0.005792:0.013143:0.006523:0.003848:0.010660:0.012508:0.012238:0.013123:0.005715:0.012508:0.013181:0.003848:0.012450:0.006523:0.012508:0.013181:0.012238:0.009333:0.010314:0.013508:0.010660:0.012238:0.011738:0.012508:0.012508:0.013181:0.007466:0.012238:0.006523:0.012604:0.012238:0.013123:0.012508:0.005330
more than 800 ml. The carbon monoxide-:@0.084848:0.623216:0.475758:0.623216:0.475758:0.607460:0.084848:0.607460:0.018049:0.012604:0.005709:0.012508:0.006581:0.006523:0.011738:0.013143:0.011738:0.006581:0.010660:0.010660:0.010660:0.005336:0.018049:0.003848:0.005330:0.006581:0.008197:0.011738:0.012508:0.006581:0.012450:0.013143:0.005792:0.013123:0.012604:0.011738:0.006581:0.018049:0.012604:0.011738:0.012604:0.009236:0.003848:0.013181:0.012508:0.006388
diffusing capacity is the best test to evalu-:@0.084848:0.639686:0.475733:0.639686:0.475733:0.623930:0.084848:0.623930:0.013181:0.003848:0.006102:0.006042:0.011699:0.007466:0.003848:0.011738:0.012950:0.005272:0.012450:0.013143:0.013123:0.013143:0.012450:0.003848:0.006523:0.010314:0.005272:0.003848:0.007466:0.005284:0.006523:0.011738:0.012508:0.005272:0.013123:0.012508:0.007466:0.006523:0.005272:0.006523:0.012508:0.007466:0.006523:0.005272:0.006523:0.012604:0.005272:0.012508:0.010660:0.013143:0.003848:0.011699:0.006388
ate the patient’s ability to tolerate chest :@0.084848:0.656156:0.481107:0.656156:0.481107:0.640400:0.084848:0.640400:0.013143:0.006523:0.012508:0.008072:0.006523:0.011738:0.012508:0.008082:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.006754:0.007466:0.008082:0.013143:0.013123:0.003848:0.003848:0.003848:0.006523:0.010314:0.008082:0.006523:0.012604:0.008066:0.006523:0.012604:0.003848:0.012508:0.005792:0.013143:0.006523:0.012508:0.008068:0.012450:0.011738:0.012508:0.007466:0.006523:0.005330
irradiation.:@0.084848:0.672627:0.183639:0.672627:0.183639:0.656871:0.084848:0.656871:0.003848:0.005792:0.005792:0.013143:0.013181:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330
5:@0.183635:0.667071:0.189850:0.667071:0.189850:0.657885:0.183635:0.657885:0.006215
The performance status (PS) of patients :@0.103030:0.689162:0.481088:0.689162:0.481088:0.673406:0.103030:0.673406:0.008197:0.011738:0.012508:0.006716:0.013123:0.012508:0.006710:0.006042:0.012604:0.006319:0.018049:0.013143:0.011738:0.012450:0.012508:0.006716:0.007466:0.006523:0.013143:0.006523:0.011699:0.007466:0.006716:0.007100:0.011392:0.009583:0.007100:0.006716:0.012604:0.006042:0.006716:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330
is the most important prognostic factor in :@0.084846:0.705632:0.481074:0.705632:0.481074:0.689876:0.084846:0.689876:0.003848:0.007466:0.006958:0.006523:0.011738:0.012508:0.006947:0.018049:0.012604:0.007466:0.006523:0.006947:0.003848:0.018049:0.013123:0.012604:0.005792:0.006523:0.013143:0.011738:0.006523:0.006937:0.013123:0.005715:0.012604:0.012950:0.011738:0.012590:0.007466:0.006523:0.003848:0.012450:0.006947:0.006042:0.013143:0.012450:0.006523:0.012604:0.005792:0.006947:0.003848:0.011738:0.005330
lung cancer and informs treatment.:@0.084846:0.722103:0.417147:0.722103:0.417147:0.706347:0.084846:0.706347:0.003848:0.011699:0.011738:0.012950:0.005330:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330:0.013143:0.011738:0.013181:0.005330:0.003848:0.011738:0.006042:0.012604:0.006300:0.018049:0.007466:0.005330:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330
Patients are assessed in terms of the World :@0.084846:0.755043:0.481097:0.755043:0.481097:0.739287:0.084846:0.739287:0.011392:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005186:0.013143:0.005713:0.012508:0.005195:0.013143:0.007466:0.007466:0.012508:0.007466:0.007466:0.012508:0.013181:0.005195:0.003848:0.011738:0.005195:0.006523:0.012508:0.006319:0.018049:0.007466:0.005195:0.012604:0.006042:0.005184:0.006523:0.011738:0.012508:0.005182:0.017589:0.012604:0.005792:0.003848:0.013181:0.005330
Health Organization (WHO) scale::@0.084846:0.771513:0.399263:0.771513:0.399263:0.755758:0.084846:0.755758:0.013143:0.012508:0.013143:0.003848:0.006523:0.011738:0.005330:0.016722:0.005807:0.012950:0.013143:0.011738:0.003848:0.008178:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.007100:0.018473:0.013143:0.016722:0.007100:0.005330:0.007466:0.012450:0.013143:0.003848:0.012508:0.005330
n   :@0.084848:0.784876:0.107657:0.784876:0.107657:0.776435:0.084848:0.776435:0.009762:0.003566:0.005914:0.003566
PS 0 – active and asymptomatic :@0.104091:0.787995:0.409756:0.787995:0.409756:0.772239:0.104091:0.772239:0.011392:0.009583:0.005330:0.010660:0.005330:0.009621:0.005330:0.013143:0.012450:0.006523:0.003848:0.010660:0.012508:0.005330:0.013143:0.011738:0.013181:0.005330:0.013143:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.013143:0.006523:0.003848:0.012450:0.005330
patient:@0.104091:0.804465:0.171497:0.804465:0.171497:0.788709:0.104091:0.788709:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523
n   :@0.084848:0.817820:0.107657:0.817820:0.107657:0.809379:0.084848:0.809379:0.009762:0.003566:0.005914:0.003566
PS 1 – symptomatic, still active:@0.104091:0.820939:0.384087:0.820939:0.384087:0.805183:0.104091:0.805183:0.011392:0.009583:0.005330:0.010660:0.005330:0.009621:0.005330:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.013143:0.006523:0.003848:0.012450:0.005330:0.005330:0.007466:0.006523:0.003848:0.003848:0.003848:0.005330:0.013143:0.012450:0.006523:0.003848:0.010660:0.012508
n   :@0.084848:0.834292:0.107657:0.834292:0.107657:0.825852:0.084848:0.825852:0.009762:0.003566:0.005914:0.003566
PS 2 – in bed less than half of the day:@0.104091:0.837411:0.448299:0.837411:0.448299:0.821655:0.104091:0.821655:0.011392:0.009583:0.005330:0.010660:0.005330:0.009621:0.005330:0.003848:0.011738:0.005330:0.013123:0.012508:0.013181:0.005330:0.003848:0.012508:0.007466:0.007466:0.005330:0.006523:0.011738:0.013143:0.011738:0.005330:0.011738:0.013143:0.003848:0.006042:0.005330:0.012604:0.006042:0.005330:0.006523:0.011738:0.012508:0.005330:0.013181:0.013143:0.010314
n   :@0.084848:0.850764:0.107657:0.850764:0.107657:0.842324:0.084848:0.842324:0.009762:0.003566:0.005914:0.003566
PS 3 – in bed more than half of the day:@0.104091:0.853883:0.465869:0.853883:0.465869:0.838127:0.104091:0.838127:0.011392:0.009583:0.005330:0.010660:0.005330:0.009621:0.005330:0.003848:0.011738:0.005330:0.013123:0.012508:0.013181:0.005330:0.018049:0.012604:0.005698:0.012508:0.005330:0.006523:0.011738:0.013143:0.011738:0.005330:0.011738:0.013143:0.003848:0.006042:0.005330:0.012604:0.006042:0.005330:0.006523:0.011738:0.012508:0.005330:0.013181:0.013143:0.010314
n   :@0.084848:0.867236:0.107657:0.867236:0.107657:0.858796:0.084848:0.858796:0.009762:0.003566:0.005914:0.003566
PS 4 – bedridden:@0.104091:0.870355:0.260397:0.870355:0.260397:0.854599:0.104091:0.854599:0.011392:0.009583:0.005330:0.010660:0.005330:0.009621:0.005330:0.013123:0.012508:0.013181:0.005792:0.003848:0.013181:0.013181:0.012508:0.011738
Patients who have a performance status :@0.084848:0.903296:0.481092:0.903296:0.481092:0.887540:0.084848:0.887540:0.011392:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.007643:0.015990:0.011738:0.012604:0.007643:0.011738:0.013143:0.010660:0.012508:0.007649:0.013143:0.007658:0.013123:0.012508:0.006710:0.006042:0.012604:0.006317:0.018049:0.013143:0.011738:0.012450:0.012508:0.007645:0.007466:0.006523:0.013143:0.006523:0.011699:0.007466:0.005330
of 3 or more are generally not candidates :@0.084848:0.919766:0.481090:0.919766:0.481090:0.904010:0.084848:0.904010:0.012604:0.006042:0.005467:0.010660:0.005474:0.012604:0.005792:0.005463:0.018049:0.012604:0.005707:0.012508:0.005471:0.013143:0.005713:0.012508:0.005471:0.012950:0.012508:0.011738:0.012508:0.005792:0.013143:0.003848:0.003848:0.010314:0.005469:0.011738:0.012604:0.006523:0.005471:0.012450:0.013143:0.011738:0.013181:0.003848:0.013181:0.013143:0.006523:0.012508:0.007466:0.005330
for curative treatment.:@0.084848:0.936236:0.295108:0.936236:0.295108:0.920481:0.084848:0.920481:0.006042:0.012604:0.005792:0.005330:0.012450:0.011699:0.005792:0.013143:0.006523:0.003848:0.010660:0.012508:0.005330:0.006523:0.005694:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330
STAGING:@0.524242:0.096077:0.627253:0.096077:0.627253:0.076481:0.524242:0.076481:0.012230:0.009878:0.017404:0.019756:0.006585:0.017404:0.019756
The stage of the disease  determines the :@0.524242:0.114742:0.920487:0.114742:0.920487:0.098986:0.524242:0.098986:0.008197:0.011738:0.012508:0.008486:0.007466:0.006523:0.013143:0.012950:0.012508:0.008486:0.012604:0.006042:0.008486:0.006523:0.011738:0.012508:0.008486:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330:0.003171:0.013181:0.012508:0.006523:0.012508:0.006321:0.018049:0.003848:0.011738:0.012508:0.007466:0.008486:0.006523:0.011738:0.012508:0.005330
prognosis  and the  intent  of  treatment. :@0.524242:0.131119:0.920501:0.131119:0.920501:0.115363:0.524242:0.115363:0.013123:0.005715:0.012604:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.005330:0.007572:0.013143:0.011738:0.013181:0.012912:0.006523:0.011738:0.012508:0.005330:0.007566:0.003848:0.011738:0.006523:0.012508:0.011738:0.006523:0.005330:0.007566:0.012604:0.006042:0.005330:0.007570:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.005330
Staging was revised in 2016.:@0.524242:0.147497:0.782334:0.147497:0.782334:0.131741:0.524242:0.131741:0.009583:0.006523:0.013143:0.012950:0.003848:0.011738:0.012950:0.005330:0.015990:0.013143:0.007466:0.005330:0.005709:0.012508:0.010660:0.003848:0.007466:0.012508:0.013181:0.005330:0.003848:0.011738:0.005330:0.010660:0.010660:0.010660:0.010660:0.005330
Stages 1,2 and selected stage 3 are usu-:@0.542426:0.163875:0.915170:0.163875:0.915170:0.148119:0.542426:0.148119:0.009583:0.006523:0.013143:0.012950:0.012508:0.007466:0.004714:0.010660:0.005330:0.010660:0.004714:0.013143:0.011738:0.013181:0.004714:0.007466:0.012508:0.003848:0.012508:0.012450:0.006523:0.012508:0.013181:0.004714:0.007466:0.006523:0.013143:0.012950:0.012508:0.004714:0.010660:0.004714:0.013143:0.005715:0.012508:0.004714:0.011699:0.007466:0.011699:0.006388
ally  treated with curative intent.  Crude :@0.524242:0.180253:0.920493:0.180253:0.920493:0.164497:0.524242:0.164497:0.013143:0.003848:0.003848:0.010314:0.005330:0.006265:0.006523:0.005709:0.012508:0.013143:0.006523:0.012508:0.013181:0.011584:0.015990:0.003848:0.006523:0.011738:0.011584:0.012450:0.011699:0.005792:0.013143:0.006523:0.003848:0.010660:0.012508:0.011584:0.003848:0.011738:0.006523:0.012508:0.011738:0.006523:0.005330:0.005330:0.006240:0.015644:0.005792:0.011699:0.013181:0.012508:0.005330
five-year survival rates range from 90% for :@0.524242:0.196630:0.920489:0.196630:0.920489:0.180874:0.524242:0.180874:0.004686:0.004686:0.010660:0.012508:0.006388:0.010314:0.012508:0.013143:0.005792:0.006410:0.007466:0.011699:0.005792:0.010660:0.003848:0.010660:0.013143:0.003848:0.006429:0.005792:0.013143:0.006523:0.012508:0.007466:0.006408:0.005792:0.013143:0.011738:0.012950:0.012508:0.006404:0.006042:0.005713:0.012604:0.018049:0.006408:0.010660:0.010660:0.014913:0.006417:0.006042:0.012604:0.005792:0.005330
stage 1 to 0% for stage 4 patients.:@0.524242:0.213008:0.837393:0.213008:0.837393:0.197252:0.524242:0.197252:0.007466:0.006523:0.013143:0.012950:0.012508:0.005330:0.010660:0.005330:0.006523:0.012604:0.005330:0.010660:0.014913:0.005330:0.006042:0.012604:0.005792:0.005330:0.007466:0.006523:0.013143:0.012950:0.012508:0.005330:0.010660:0.005330:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330
6:@0.837363:0.207350:0.843578:0.207350:0.843578:0.198165:0.837363:0.198165:0.006215
STAGE I:@0.524242:0.246035:0.601211:0.246035:0.601211:0.228220:0.524242:0.228220:0.011118:0.008980:0.015822:0.017960:0.011118:0.005987:0.005987
Stage 1 includes patients with operable :@0.524242:0.263553:0.920462:0.263553:0.920462:0.247797:0.524242:0.247797:0.009583:0.006523:0.013143:0.012950:0.012508:0.009833:0.010660:0.009833:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.007466:0.009833:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.009833:0.015990:0.003848:0.006523:0.011738:0.009833:0.012604:0.013123:0.012508:0.005792:0.013143:0.013123:0.003848:0.012508:0.005330
primary tumours  of less  than or equal to :@0.524242:0.279931:0.920483:0.279931:0.920483:0.264175:0.524242:0.264175:0.013123:0.005792:0.003848:0.018049:0.013143:0.005792:0.010314:0.008871:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.005330:0.003531:0.012604:0.006042:0.008871:0.003848:0.012508:0.007466:0.007466:0.005330:0.003552:0.006523:0.011738:0.013143:0.011738:0.008871:0.012604:0.005792:0.008871:0.012508:0.013123:0.011699:0.013143:0.003848:0.008871:0.006523:0.012604:0.005330
4 cm in size and no nodal involvement.:@0.524242:0.296308:0.887231:0.296308:0.887231:0.280552:0.524242:0.280552:0.010660:0.005330:0.012450:0.018049:0.005330:0.003848:0.011738:0.005330:0.007466:0.003848:0.008178:0.012508:0.005330:0.013143:0.011738:0.013181:0.005330:0.011738:0.012604:0.005330:0.011738:0.012604:0.013181:0.013143:0.003848:0.005330:0.003848:0.011738:0.010660:0.012604:0.003848:0.010660:0.012508:0.018049:0.012508:0.011738:0.006523:0.005330
The  cornerstone  of  treatment  is sur-:@0.542426:0.312686:0.915159:0.312686:0.915159:0.296930:0.542426:0.296930:0.008197:0.011738:0.012508:0.005330:0.009396:0.012450:0.012604:0.006192:0.011738:0.012508:0.005792:0.007466:0.006523:0.012604:0.011738:0.012508:0.005330:0.009388:0.012604:0.006042:0.005330:0.009398:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.009394:0.003848:0.007466:0.014740:0.007466:0.011699:0.005792:0.006388
gery, most often a lobectomy as this has :@0.524242:0.329064:0.920472:0.329064:0.920472:0.313308:0.524242:0.313308:0.012950:0.012508:0.005792:0.010314:0.005330:0.007466:0.018049:0.012604:0.007466:0.006523:0.007466:0.012604:0.006042:0.006523:0.012508:0.011738:0.007456:0.013143:0.007466:0.003848:0.012604:0.013123:0.012508:0.012450:0.006523:0.012604:0.018049:0.010314:0.007466:0.013143:0.007466:0.007466:0.006523:0.011738:0.003848:0.007466:0.007466:0.011738:0.013143:0.007466:0.005330
a lower morbidity and mortality than a :@0.524242:0.345428:0.920489:0.345428:0.920489:0.329672:0.524242:0.329672:0.013143:0.010795:0.003848:0.012604:0.015990:0.012508:0.005792:0.010795:0.018049:0.012604:0.005792:0.013123:0.003848:0.013181:0.003848:0.006523:0.010314:0.010795:0.013143:0.011738:0.013181:0.010795:0.018049:0.012604:0.005792:0.006512:0.013143:0.003848:0.003848:0.006523:0.010314:0.010795:0.006523:0.011738:0.013143:0.011738:0.010795:0.013143:0.005330
pneumonectomy (4%:@0.524242:0.361806:0.727705:0.361806:0.727705:0.346050:0.524242:0.346050:0.013123:0.011738:0.012508:0.011699:0.018049:0.012604:0.011738:0.012508:0.012450:0.006523:0.012604:0.018049:0.010314:0.006883:0.007100:0.010660:0.014913
 versus:@0.727705:0.361806:0.790205:0.361806:0.790205:0.346050:0.727705:0.346050:0.006908:0.010660:0.012508:0.005792:0.007466:0.011699:0.007466
 9%). Patients :@0.790205:0.361806:0.920495:0.361806:0.920495:0.346050:0.790205:0.346050:0.006908:0.010660:0.014913:0.007100:0.005330:0.006908:0.011392:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330
with minimally-invasive  adenocarcinoma :@0.524242:0.378184:0.920483:0.378184:0.920483:0.362428:0.524242:0.362428:0.015990:0.003848:0.006523:0.011738:0.009794:0.018049:0.003848:0.011738:0.003848:0.018049:0.013143:0.003848:0.003848:0.010314:0.006402:0.003848:0.011738:0.010660:0.013143:0.007466:0.003848:0.010660:0.012508:0.005330:0.004476:0.013143:0.013181:0.012508:0.011738:0.012604:0.012450:0.013143:0.005653:0.012450:0.003848:0.011738:0.012604:0.018049:0.013143:0.005330
may be treated by focal excision. These :@0.524242:0.394561:0.920456:0.394561:0.920456:0.378805:0.524242:0.378805:0.018049:0.013143:0.010314:0.008447:0.013123:0.012508:0.008447:0.006523:0.005709:0.012508:0.013143:0.006523:0.012508:0.013181:0.008447:0.013123:0.010314:0.008447:0.006042:0.012604:0.012450:0.013143:0.003848:0.008447:0.012508:0.009236:0.012450:0.003848:0.007466:0.003848:0.012604:0.011738:0.005330:0.008447:0.008197:0.011738:0.012508:0.007466:0.012508:0.005330
tumours  spread along  the  airways rather :@0.524242:0.410939:0.920497:0.410939:0.920497:0.395183:0.524242:0.395183:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.005330:0.003002:0.007466:0.013123:0.005719:0.012508:0.013143:0.013181:0.008351:0.013143:0.003848:0.012604:0.011738:0.012950:0.005330:0.003010:0.006523:0.011738:0.012508:0.005330:0.003006:0.013143:0.003848:0.005792:0.015990:0.013143:0.010314:0.007466:0.008351:0.005792:0.013143:0.006523:0.011738:0.012508:0.005792:0.005330
than through the lymphatics.:@0.524242:0.427317:0.792927:0.427317:0.792927:0.411561:0.524242:0.411561:0.006523:0.011738:0.013143:0.011738:0.005330:0.006523:0.011738:0.005700:0.012604:0.011699:0.012950:0.011738:0.005330:0.006523:0.011738:0.012508:0.005330:0.003848:0.010314:0.018049:0.013123:0.011738:0.013143:0.006523:0.003848:0.012450:0.007466:0.005330
Patients  who  are medically inoperable :@0.542426:0.443694:0.920478:0.443694:0.920478:0.427939:0.542426:0.427939:0.011392:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.003281:0.015990:0.011738:0.012604:0.005330:0.003281:0.013143:0.005711:0.012508:0.008621:0.018049:0.012508:0.013181:0.003848:0.012450:0.013143:0.003848:0.003848:0.010314:0.008621:0.003848:0.011738:0.012604:0.013123:0.012508:0.005792:0.013143:0.013123:0.003848:0.012508:0.005330
may be treated by  high-dose external-:@0.524242:0.460072:0.915128:0.460072:0.915128:0.444316:0.524242:0.444316:0.018049:0.013143:0.010314:0.011141:0.013123:0.012508:0.011141:0.006523:0.005709:0.012508:0.013143:0.006523:0.012508:0.013181:0.011141:0.013123:0.010314:0.005330:0.005823:0.011738:0.003848:0.012950:0.011738:0.006388:0.013181:0.012604:0.007466:0.012508:0.011141:0.012508:0.009236:0.006523:0.012508:0.006186:0.011738:0.013143:0.003848:0.006388
beam radiation. This would comprise the :@0.524242:0.476450:0.920462:0.476450:0.920462:0.460694:0.524242:0.460694:0.013123:0.012508:0.013143:0.018049:0.007947:0.005792:0.013143:0.013181:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.007947:0.008197:0.011738:0.003848:0.007466:0.007947:0.015990:0.012604:0.011699:0.003848:0.013181:0.007947:0.012450:0.012604:0.018049:0.013123:0.005792:0.003848:0.007466:0.012508:0.007947:0.006523:0.011738:0.012508:0.005330
daily course  of  external-beam  irradiation :@0.524242:0.492828:0.920485:0.492828:0.920485:0.477072:0.524242:0.477072:0.013181:0.013143:0.003848:0.003848:0.010314:0.008274:0.012450:0.012604:0.011699:0.005792:0.007466:0.012508:0.005330:0.002927:0.012604:0.006042:0.005330:0.002931:0.012508:0.009236:0.006523:0.012508:0.006186:0.011738:0.013143:0.003848:0.006388:0.013123:0.012508:0.013143:0.018049:0.005330:0.002931:0.003848:0.005792:0.005792:0.013143:0.013181:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330
to more than 60 Gray. Whole-body stereo- :@0.524242:0.509205:0.920510:0.509205:0.920510:0.493449:0.524242:0.493449:0.006523:0.012604:0.004772:0.018049:0.012604:0.005707:0.012508:0.004772:0.006523:0.011738:0.013143:0.011738:0.004772:0.010660:0.010660:0.004772:0.016779:0.005792:0.013143:0.010314:0.005330:0.004772:0.018473:0.011738:0.012604:0.003848:0.012508:0.006388:0.013123:0.012604:0.013181:0.010314:0.004772:0.007466:0.006523:0.012508:0.005713:0.012508:0.012604:0.006388:0.005330
taxis with high-ablatant doses of irradia-:@0.524242:0.525583:0.915132:0.525583:0.915132:0.509827:0.524242:0.509827:0.006523:0.013143:0.009236:0.003848:0.007466:0.009544:0.015990:0.003848:0.006523:0.011738:0.009544:0.011738:0.003848:0.012950:0.011738:0.006388:0.013143:0.013123:0.003848:0.013143:0.006523:0.013143:0.011738:0.006523:0.009544:0.013181:0.012604:0.007466:0.012508:0.007466:0.009544:0.012604:0.006042:0.009544:0.003848:0.005792:0.005792:0.013143:0.013181:0.003848:0.013143:0.006388
tion given in a few sessions is the preferred :@0.524242:0.541961:0.920495:0.541961:0.920495:0.526205:0.524242:0.526205:0.006523:0.003848:0.012604:0.011738:0.005180:0.012950:0.003848:0.010660:0.012508:0.011738:0.005184:0.003848:0.011738:0.005195:0.013143:0.005195:0.006042:0.012508:0.015990:0.005186:0.007466:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.007466:0.005195:0.003848:0.007466:0.005195:0.006523:0.011738:0.012508:0.005180:0.013123:0.005715:0.012508:0.006042:0.012508:0.005792:0.005703:0.012508:0.013181:0.005330
therapy.  Control rates at two  years of :@0.524242:0.558338:0.920506:0.558338:0.920506:0.542582:0.524242:0.542582:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.005330:0.007281:0.015644:0.012604:0.011738:0.006523:0.005703:0.012604:0.003848:0.012623:0.005792:0.013143:0.006523:0.012508:0.007466:0.012623:0.013143:0.006523:0.012623:0.006523:0.015990:0.012604:0.005330:0.007283:0.010314:0.012508:0.013143:0.005792:0.007466:0.012623:0.012604:0.006042:0.005330
more than 90% are being reported.:@0.524242:0.574716:0.851930:0.574716:0.851930:0.558960:0.524242:0.558960:0.018049:0.012604:0.005709:0.012508:0.005330:0.006523:0.011738:0.013143:0.011738:0.005330:0.010660:0.010660:0.014913:0.005330:0.013143:0.005703:0.012508:0.005330:0.013123:0.012508:0.003848:0.011738:0.012950:0.005330:0.005703:0.012508:0.013123:0.012604:0.005792:0.006523:0.012508:0.013181:0.005330
7:@0.851917:0.568987:0.858132:0.568987:0.858132:0.559802:0.851917:0.559802:0.006215
Patients with the resected stage I dis-:@0.542424:0.590978:0.915147:0.590978:0.915147:0.575222:0.542424:0.575222:0.011392:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.010006:0.015990:0.003848:0.006523:0.011738:0.010006:0.006523:0.011738:0.012508:0.010006:0.005713:0.012508:0.007466:0.012508:0.012450:0.006523:0.012508:0.013181:0.010006:0.007466:0.006523:0.013143:0.012950:0.012508:0.010006:0.004349:0.010006:0.013181:0.003848:0.007466:0.006388
ease are  at  risk of  developing  a second :@0.524240:0.607355:0.920502:0.607355:0.920502:0.591599:0.524240:0.591599:0.012508:0.013143:0.007466:0.012508:0.008409:0.013143:0.005713:0.012508:0.005330:0.003067:0.013143:0.006523:0.005330:0.003067:0.005792:0.003848:0.007466:0.009660:0.008409:0.012604:0.006042:0.005330:0.003063:0.013181:0.012508:0.010660:0.012508:0.003848:0.012604:0.013123:0.003848:0.011738:0.012950:0.005330:0.003065:0.013143:0.008409:0.007466:0.012508:0.012450:0.012604:0.011738:0.013181:0.005330
lung cancer. This risk increases if the pa-:@0.524240:0.623733:0.915114:0.623733:0.915114:0.607977:0.524240:0.607977:0.003848:0.011699:0.011738:0.012950:0.008640:0.012450:0.013143:0.011738:0.012450:0.012508:0.004374:0.005330:0.008640:0.008197:0.011738:0.003848:0.007466:0.008640:0.005792:0.003848:0.007466:0.009660:0.008640:0.003848:0.011738:0.012450:0.005713:0.012508:0.013143:0.007466:0.012508:0.007466:0.008640:0.003848:0.006042:0.008640:0.006523:0.011738:0.012508:0.008640:0.013123:0.013143:0.006388
tient continues smoking. :@0.524240:0.640111:0.753590:0.640111:0.753590:0.624355:0.524240:0.624355:0.006523:0.003848:0.012508:0.011738:0.006523:0.005330:0.012450:0.012604:0.011738:0.006523:0.003848:0.011738:0.011699:0.012508:0.007466:0.005330:0.007466:0.018049:0.012604:0.009660:0.003848:0.011738:0.012950:0.005330:0.005330
8:@0.753563:0.634472:0.759778:0.634472:0.759778:0.625287:0.753563:0.625287:0.006215
STAGE II:@0.524242:0.673157:0.607198:0.673157:0.607198:0.655342:0.524242:0.655342:0.011118:0.008980:0.015822:0.017960:0.011118:0.005987:0.005987:0.005987
Stage II includes patients with potentially :@0.524242:0.690675:0.920454:0.690675:0.920454:0.674919:0.524242:0.674919:0.009583:0.006523:0.013143:0.012950:0.012508:0.007947:0.004349:0.004349:0.007947:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.007466:0.007959:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.007947:0.015990:0.003848:0.006523:0.011738:0.007947:0.013123:0.012604:0.006523:0.012508:0.011738:0.006523:0.003848:0.013143:0.003848:0.003848:0.010314:0.005330
operable tumours that  are more than :@0.524242:0.707053:0.920512:0.707053:0.920512:0.691297:0.524242:0.691297:0.012604:0.013123:0.012508:0.005792:0.013143:0.013123:0.003848:0.012508:0.013835:0.006523:0.011699:0.018049:0.012594:0.011699:0.005792:0.007466:0.013835:0.006523:0.011738:0.013143:0.006523:0.005330:0.008494:0.013143:0.005715:0.012508:0.013835:0.018049:0.012604:0.005709:0.012508:0.013835:0.006523:0.011738:0.013143:0.011738:0.005330
4  cm  with  or  without  involvement  of  the :@0.524242:0.723430:0.920497:0.723430:0.920497:0.707675:0.524242:0.707675:0.010660:0.005330:0.003290:0.012450:0.018049:0.005330:0.003277:0.015990:0.003848:0.006523:0.011738:0.005330:0.003277:0.012604:0.005792:0.005330:0.003269:0.015990:0.003848:0.006523:0.011738:0.012604:0.011699:0.006523:0.005330:0.003269:0.003848:0.011738:0.010660:0.012604:0.003848:0.010660:0.012508:0.018049:0.012508:0.011738:0.006523:0.005330:0.003277:0.012604:0.006042:0.005330:0.003273:0.006523:0.011738:0.012508:0.005330
hilar nodes.:@0.524242:0.739808:0.630768:0.739808:0.630768:0.724052:0.524242:0.724052:0.011738:0.003848:0.003848:0.013143:0.005792:0.005330:0.011738:0.012604:0.013181:0.012508:0.007466:0.005330
Surgery,  as described above, remains :@0.542426:0.756186:0.920479:0.756186:0.920479:0.740430:0.542426:0.740430:0.009583:0.011699:0.005805:0.012950:0.012508:0.005792:0.010314:0.005330:0.005330:0.005723:0.013143:0.007466:0.011064:0.013181:0.012508:0.007466:0.012450:0.005792:0.003848:0.013123:0.012508:0.013181:0.011064:0.013143:0.013123:0.012604:0.010660:0.012508:0.005330:0.011064:0.005711:0.012508:0.018049:0.013143:0.003848:0.011738:0.007466:0.005330
the cornerstone of treatment for patients :@0.524242:0.772564:0.920479:0.772564:0.920479:0.756808:0.524242:0.756808:0.006523:0.011738:0.012508:0.007370:0.012450:0.012604:0.006188:0.011738:0.012508:0.005792:0.007466:0.006523:0.012604:0.011722:0.012508:0.007376:0.012604:0.006042:0.007374:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006514:0.007378:0.006042:0.012604:0.005792:0.007370:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330
in this stage. Patients who have chest-wall :@0.524242:0.788941:0.920499:0.788941:0.920499:0.773185:0.524242:0.773185:0.003848:0.011738:0.005407:0.006523:0.011738:0.003848:0.007466:0.005407:0.007466:0.006523:0.013143:0.012950:0.012508:0.005330:0.005397:0.011392:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005407:0.015990:0.011738:0.012604:0.005396:0.011738:0.013143:0.010660:0.012508:0.005407:0.012450:0.011738:0.012508:0.007466:0.006523:0.006388:0.015990:0.013143:0.003848:0.003848:0.005330
involvement should be considered for :@0.524242:0.805319:0.920485:0.805319:0.920485:0.789563:0.524242:0.789563:0.003848:0.011738:0.010660:0.012604:0.003848:0.010660:0.012508:0.018049:0.012508:0.011738:0.006523:0.015105:0.007466:0.011738:0.012604:0.011699:0.003848:0.013181:0.015105:0.013123:0.012508:0.015105:0.012450:0.012604:0.011738:0.007466:0.003848:0.013181:0.012508:0.005719:0.012508:0.013181:0.015105:0.006042:0.012604:0.005792:0.005330
chest-wall resection.:@0.524242:0.821697:0.714166:0.821697:0.714166:0.805941:0.524242:0.805941:0.012450:0.011738:0.012508:0.007466:0.006523:0.006388:0.015990:0.013143:0.003848:0.003848:0.005330:0.005717:0.012508:0.007466:0.012508:0.012450:0.006523:0.003848:0.012604:0.011738:0.005330
Adjuvant chemotherapy  increases the :@0.542426:0.838074:0.920485:0.838074:0.920485:0.822318:0.542426:0.822318:0.014239:0.013181:0.003906:0.011699:0.010660:0.013143:0.011738:0.006523:0.009852:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.004508:0.003848:0.011738:0.012450:0.005713:0.012508:0.013143:0.007466:0.012508:0.007466:0.009852:0.006523:0.011738:0.012508:0.005330
survival  rate in this group of patients by :@0.524242:0.854452:0.920489:0.854452:0.920489:0.838696:0.524242:0.838696:0.007466:0.011699:0.005792:0.010660:0.003848:0.010660:0.013143:0.003848:0.005330:0.004343:0.005792:0.013143:0.006523:0.012508:0.009660:0.003848:0.011738:0.009660:0.006523:0.011738:0.003848:0.007466:0.009660:0.012950:0.005709:0.012604:0.011699:0.013123:0.009660:0.012604:0.006042:0.009660:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.009660:0.013123:0.010314:0.005330
5% at five years.  Patients with stage II and :@0.524242:0.870817:0.920479:0.870759:0.920479:0.855003:0.524242:0.855061:0.010660:0.014913:0.005224:0.013143:0.006523:0.005219:0.004686:0.004686:0.010660:0.012508:0.005219:0.010314:0.012508:0.013143:0.005792:0.007466:0.005330:0.006221:0.005222:0.011392:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005219:0.015990:0.003848:0.006523:0.011738:0.005220:0.007466:0.006523:0.013143:0.012950:0.012508:0.005220:0.004349:0.004349:0.005224:0.013143:0.011738:0.013181:-0.704244
9:@0.672237:0.865140:0.678452:0.865140:0.678452:0.855954:0.672237:0.855954:0.006215
stage IIIA disease derive maximal benefit.  :@0.524246:0.887136:0.920481:0.887130:0.920481:0.871374:0.524246:0.871380:0.007466:0.006523:0.013143:0.012950:0.012508:0.003910:0.004349:0.004349:0.004349:0.014239:0.003912:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.003922:0.013181:0.012508:0.005792:0.003848:0.010660:0.012508:0.003912:0.018049:0.013143:0.009236:0.003848:0.018049:0.013143:0.003848:0.003922:0.013123:0.012508:0.011738:0.012508:0.004686:0.004686:0.006523:0.005330:0.012418:-0.728058
10:@0.902716:0.881511:0.915146:0.881511:0.915146:0.872325:0.902716:0.872325:0.006215:0.006215
The agents most consistently used in trials :@0.524241:0.903508:0.920506:0.903508:0.920506:0.887752:0.524241:0.887752:0.008197:0.011738:0.012508:0.006895:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.006908:0.018049:0.012604:0.007466:0.006523:0.006908:0.012450:0.012604:0.011738:0.007466:0.003848:0.007466:0.006523:0.012508:0.011738:0.006523:0.003848:0.010314:0.006908:0.011699:0.007466:0.012508:0.013181:0.006908:0.003848:0.011738:0.006908:0.006523:0.005792:0.003848:0.013143:0.003848:0.007466:0.005330
for adjuvant chemotherapy are one of the :@0.524241:0.919885:0.920485:0.919885:0.920485:0.904129:0.524241:0.904129:0.006042:0.012604:0.005792:0.004058:0.013143:0.013181:0.003906:0.011699:0.010660:0.013143:0.011738:0.006523:0.004068:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.004056:0.013143:0.005713:0.012508:0.004064:0.012604:0.011738:0.012508:0.004058:0.012604:0.006042:0.004062:0.006523:0.011738:0.012508:0.005330
platinums and vinorelbine. Carboplatin is :@0.524241:0.936263:0.920479:0.936263:0.920479:0.920507:0.524241:0.920507:0.013123:0.003848:0.013143:0.006523:0.003848:0.011738:0.011699:0.018049:0.007466:0.008024:0.013143:0.011738:0.013181:0.008024:0.010660:0.003848:0.011738:0.012604:0.005713:0.012508:0.003848:0.013123:0.003848:0.011738:0.012508:0.005330:0.008024:0.015644:0.013143:0.005792:0.013123:0.012604:0.013123:0.003848:0.013143:0.006523:0.003848:0.011738:0.008024:0.003848:0.007466:0.005330